Orthofix Announces Participation in Upcoming Credit Suisse and Stifel Healthcare Conferences
Get Alerts OFIX Hot Sheet
Join SI Premium – FREE
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in two upcoming virtual investor conferences.
Credit Suisse 30th Annual Healthcare Conference
The Company will be presenting on Wednesday, November 10, 2021 at 3:30pm EST.
Stifel 2021 Virtual Healthcare Conference
The Company will be presenting on Wednesday, November 17, 2021 at 2:40pm EST.
Live audio webcasts will be available on the Company’s website at ir.orthofix.com/events-and-presentations/.
About Orthofix
Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company’s mission is to deliver innovative, quality-driven solutions while partnering with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedics products are distributed in more than 60 countries via the Company's sales representatives and distributors. For more information, please visit www.orthofix.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211103005903/en/
Alexa Huerta
Investor Relations
Tel 214 937 3190
[email protected]
Denise Landry
Media Relations
Tel 214 937 2529
[email protected]
Source: Orthofix Medical Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orthofix Medical stock surges on Medicare reimbursement reversal
- The Walking Dead Universe FAST channel goes live on ITVX as part of UK rollout
- Latecoere: Half-Year Report on the Liquidity Contract Entered Into With NATIXIS ODDO BHF
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Credit Suisse, StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share